Matches in SemOpenAlex for { <https://semopenalex.org/work/W1986943635> ?p ?o ?g. }
Showing items 1 to 88 of
88
with 100 items per page.
- W1986943635 endingPage "111" @default.
- W1986943635 startingPage "106" @default.
- W1986943635 abstract "Abstract Purpose To prospectively investigate, by means of a pre‐and postexamination questionnaire, the types and frequency of adverse reactions to ferucarbotran (Resovist), a superparamagnetic iron oxide (SPIO) contrast agent. Materials and Methods This study was approved by the ethics committee of each of the institutions involved, and all patients gave written informed consent. One questionnaire asking about baseline symptoms before the injection of ferucarbotran, and one about adverse events over a period of seven days after injection were given to 315 patients who underwent ferucarbotran‐enhanced magnetic resonance imaging (MRI) of the liver at several institutions. The data for baseline symptoms were used for reference to exclude false‐positive adverse reactions and were also compared with the adverse event data to determine with McNemar's chi‐squared test the incidence of each symptom. Results Before MR examination, 249 clinical symptoms were reported by 102 of 315 patients (32.4%). After the injection of ferucarbotran, 169 adverse events were observed in 78 patients (24.8%). Eventually, 70 adverse events occurring in 45 patients (14.3%) were judged to be adverse reactions to ferucarbotran, defined as possibly or definitely ferucarbotran‐related events. All reactions were of mild intensity. Conclusion Ferucarbotran can be considered safe for clinical use in liver MRI. J. Magn. Reson. Imaging 2009;29:106–111. © 2008 Wiley‐Liss, Inc." @default.
- W1986943635 created "2016-06-24" @default.
- W1986943635 creator A5003394557 @default.
- W1986943635 creator A5007789548 @default.
- W1986943635 creator A5024196878 @default.
- W1986943635 creator A5025946910 @default.
- W1986943635 creator A5043394179 @default.
- W1986943635 creator A5047793340 @default.
- W1986943635 creator A5051443235 @default.
- W1986943635 creator A5074130361 @default.
- W1986943635 creator A5085951307 @default.
- W1986943635 creator A5087133884 @default.
- W1986943635 date "2008-12-18" @default.
- W1986943635 modified "2023-10-18" @default.
- W1986943635 title "Safety of ferucarbotran in MR imaging of the liver: A pre- and postexamination questionnaire-based multicenter investigation" @default.
- W1986943635 cites W1560609297 @default.
- W1986943635 cites W2017128978 @default.
- W1986943635 cites W2078131849 @default.
- W1986943635 cites W2084153332 @default.
- W1986943635 cites W2090303705 @default.
- W1986943635 cites W2095284373 @default.
- W1986943635 cites W2110118058 @default.
- W1986943635 cites W2148815670 @default.
- W1986943635 cites W2163391474 @default.
- W1986943635 doi "https://doi.org/10.1002/jmri.21608" @default.
- W1986943635 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19097079" @default.
- W1986943635 hasPublicationYear "2008" @default.
- W1986943635 type Work @default.
- W1986943635 sameAs 1986943635 @default.
- W1986943635 citedByCount "15" @default.
- W1986943635 countsByYear W19869436352012 @default.
- W1986943635 countsByYear W19869436352013 @default.
- W1986943635 countsByYear W19869436352015 @default.
- W1986943635 countsByYear W19869436352017 @default.
- W1986943635 countsByYear W19869436352019 @default.
- W1986943635 countsByYear W19869436352020 @default.
- W1986943635 countsByYear W19869436352021 @default.
- W1986943635 crossrefType "journal-article" @default.
- W1986943635 hasAuthorship W1986943635A5003394557 @default.
- W1986943635 hasAuthorship W1986943635A5007789548 @default.
- W1986943635 hasAuthorship W1986943635A5024196878 @default.
- W1986943635 hasAuthorship W1986943635A5025946910 @default.
- W1986943635 hasAuthorship W1986943635A5043394179 @default.
- W1986943635 hasAuthorship W1986943635A5047793340 @default.
- W1986943635 hasAuthorship W1986943635A5051443235 @default.
- W1986943635 hasAuthorship W1986943635A5074130361 @default.
- W1986943635 hasAuthorship W1986943635A5085951307 @default.
- W1986943635 hasAuthorship W1986943635A5087133884 @default.
- W1986943635 hasConcept C105795698 @default.
- W1986943635 hasConcept C126322002 @default.
- W1986943635 hasConcept C126838900 @default.
- W1986943635 hasConcept C143409427 @default.
- W1986943635 hasConcept C186282968 @default.
- W1986943635 hasConcept C197934379 @default.
- W1986943635 hasConcept C2989005 @default.
- W1986943635 hasConcept C33923547 @default.
- W1986943635 hasConcept C71924100 @default.
- W1986943635 hasConceptScore W1986943635C105795698 @default.
- W1986943635 hasConceptScore W1986943635C126322002 @default.
- W1986943635 hasConceptScore W1986943635C126838900 @default.
- W1986943635 hasConceptScore W1986943635C143409427 @default.
- W1986943635 hasConceptScore W1986943635C186282968 @default.
- W1986943635 hasConceptScore W1986943635C197934379 @default.
- W1986943635 hasConceptScore W1986943635C2989005 @default.
- W1986943635 hasConceptScore W1986943635C33923547 @default.
- W1986943635 hasConceptScore W1986943635C71924100 @default.
- W1986943635 hasIssue "1" @default.
- W1986943635 hasLocation W19869436351 @default.
- W1986943635 hasLocation W19869436352 @default.
- W1986943635 hasOpenAccess W1986943635 @default.
- W1986943635 hasPrimaryLocation W19869436351 @default.
- W1986943635 hasRelatedWork W1766395648 @default.
- W1986943635 hasRelatedWork W1964160057 @default.
- W1986943635 hasRelatedWork W2064023586 @default.
- W1986943635 hasRelatedWork W2149889956 @default.
- W1986943635 hasRelatedWork W2473965482 @default.
- W1986943635 hasRelatedWork W2601473374 @default.
- W1986943635 hasRelatedWork W3151422078 @default.
- W1986943635 hasRelatedWork W4232149648 @default.
- W1986943635 hasRelatedWork W4250308522 @default.
- W1986943635 hasRelatedWork W4280574918 @default.
- W1986943635 hasVolume "29" @default.
- W1986943635 isParatext "false" @default.
- W1986943635 isRetracted "false" @default.
- W1986943635 magId "1986943635" @default.
- W1986943635 workType "article" @default.